98%
921
2 minutes
20
Background: The 2025 American Academy of Sleep Medicine (AASM) clinical practice guideline for the treatment of Restless Legs Syndrome (RLS) and Periodic Limb Movement Disorder (PLMD) provides updated, evidence-based recommendations. The World Sleep Society (WSS) conducted an international review to assess the guideline's global applicability and implementation feasibility.
Methods: A structured questionnaire was distributed to representatives of 53 national sleep societies affiliated with the WSS. The survey addressed guideline familiarity, perceived applicability, agreement with 20 treatment recommendations, and availability of key therapies. Responses were analyzed using descriptive statistics and the within-group interrater agreement coefficient (rWG) to assess consensus levels.
Results: Twenty-three national societies (43.9 %) from all inhabited continents responded. The AASM guideline was perceived as fully or partially applicable in most countries. Twelve recommendations were fully supported by the WSS, five partially supported, two (regarding dopamine agonists) endorsed with caveats, and one (dipyridamole) not supported. Key barriers included limited access to certain medications (e.g., IV iron, gabapentin enacarbil), regulatory restrictions, and divergent treatment traditions. There was strong global consensus on discouraging ineffective or harmful treatments (e.g., cabergoline, valproic acid), while the avoidance of dopaminergic agents generated regional disagreement.
Conclusions: The AASM guidelines received broad international support but require region-specific adaptation for optimal implementation. The WSS endorses the guideline's structure and scientific foundation while recommending flexible dissemination strategies and greater clarity in therapeutic algorithms. These findings support the development of globally relevant, context-sensitive guidance in sleep medicine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.sleep.2025.106734 | DOI Listing |
Front Neurol
August 2025
Unit of Child Neurology and Psychiatry, Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.
Introduction: Restless Legs Syndrome (RLS), known as Willis-Ekbom disease, is a common neurological condition that often goes undiagnosed, especially in children. Characterized by an irresistible urge to move the legs, it is typically more pronounced in the evening and at rest. Growing Pains (GP), common in childhood and associated with migraine, present apparently overlapping symptoms with RLS, making it sometimes difficult to distinguish between the two.
View Article and Find Full Text PDFSleep Med Clin
September 2025
Sleep Research Institute, Calle Padre Damián, Madrid, Spain; Instituto Europeo del Sueño, Panama. Electronic address:
Restless legs syndrome (RLS) frequently coexists with Parkinson's disease (PD), significantly contributing to sleep disturbances and reduced quality of life. This review examines the prevalence, clinical features, pathophysiology, and treatment of RLS in patients with PD. Although prevalence estimates vary due to differences in diagnostic criteria and assessment methods, RLS is consistently linked to a greater burden of nonmotor symptoms, including sleep disruption, depression, and cognitive impairment, which further complicate disease management.
View Article and Find Full Text PDFSleep Med Clin
September 2025
Older Person Medical Clinic, Suite 3/18 Lambton Road, Broadmeadow, New South Wales, 2292, Australia.
Sleep and circadian disturbances are prevalent in Parkinson's disease (PD) and become increasingly complex in older adults, where aging-related changes, comorbidities, and polypharmacy further disrupt sleep. This review explores the pathophysiology of sleep and circadian dysfunction in aging and PD, highlighting the impact of neurodegenerative changes and neurotransmitter dysregulation. Key sleep disorders in older adults with PD are discussed with a focus on their epidemiology, assessment, and tailored management.
View Article and Find Full Text PDFSleep Med Clin
September 2025
Department of Neurology, National Neuroscience Institute, Singapore 308433, Singapore; Signature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore; Neuroscience Academic Clinical Program, Duke-NUS Medical School, Singapore
Sleep dysfunction in Parkinson's disease (PD) includes rapid eye movement sleep behavior disorder, restless leg syndrome, and excessive daytime sleepiness. These sleep-related manifestations may serve as prodromal signs of PD, particularly in carriers of pathogenic mutations in the genes implicated in familial and sporadic forms of PD. Study findings underscore the importance of differentiating mutation-specific sleep phenotypes in PD.
View Article and Find Full Text PDFRestless legs syndrome (RLS) has a multifactorial etiology, and current treatments are suboptimal. Micronutrients influence neuromuscular and dopaminergic function, yet their causal role in RLS is uncertain. This study aimed to investigate whether circulating micronutrients causally influence the risk of RLS by applying an integrated two-sample, bidirectional, and multivariable Mendelian Randomization (MR) strategy.
View Article and Find Full Text PDF